Synthesis and characterization of bis-amide SSE1917 as a microtubule-stabilizing anticancer agent
Synthesis and characterization of bis-amide SSE1917 as a microtubule-stabilizing anticancer agent
复制标题
DOI:
10.1016/j.bioorg.2023.107094
复制
发表时间:
2024-01-09
影响因子:
5.1
通讯作者:
Saleem,Rahman Shah Zaib
中科院分区:
文献类型:
--
作者:
Iqbal,Sana;Firdous,Farhat;Saleem,Rahman Shah Zaib
Microtubule dynamics are critical for spindle assembly and chromosome segregation during cell division. Pharmacological inhibition of microtubule dynamics in cells causes prolonged mitotic arrest, resulting in apoptosis, an approach extensively employed in treating different types of cancers. The present study reports the synthesis of thirty-two novel bis-amides(SSE1901-SSE1932)and the evaluation of their antiproliferative activities.N-(1-oxo-3-phenyl-1-(phenylamino)propan-2-yl)benzamide (SSE1917)exhibited the most potent activity with GI50values of 0.331 ± 0.01 µM in HCT116 colorectal and 0.48 ± 0.27 µM in BT-549 breast cancer cells.SSE1917stabilized microtubules in biochemical and cellular assays, bound to taxol site in docking studies, and caused aberrant mitosis and G2/M arrest in cells. Prolonged treatment of cells with the compound increased p53 expression and triggered apoptotic cell death. Furthermore,SSE1917suppressed the growth of both mouse and patient-derived human colon cancer organoids, highlighting its potential therapeutic value as an anticancer agent.